| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5647247 | The Journal of Allergy and Clinical Immunology: In Practice | 2017 | 10 Pages |
Abstract
NSAID therapeutic use can be limited by ADRs; about 1 in 5 NSAID ADRs is an HSR. Both patient and drug factors contribute to HSR risk and are important to guide patient counseling.
Keywords
NSAIDAERDADRPHSICD-9HSRCOX-2Aspirin-exacerbated respiratory diseaseAllergyElectronic Health RecordHypersensitivityDrugnonsteroidal anti-inflammatory drugoral routecyclooxygenase 2International Classification of Diseases, Ninth EditionAdverse drug reactionSide effectodds ratioHypersensitivity reactionAdverse reactionEHRPear
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kimberly G. MD, Kenneth H. MA, Mingshu PhD, MA, Zachary S. MD, Paige G. MD, MPH, Li MD, PhD,